Search Results 241-250 of 17671 for Glucocorticoids

1. A Study Of CC-97540, CD-19-Targeted Nex-T CAR T Cells, In Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1) - Mayo Clinic

   ii) Inadequate response to glucocorticoids and to at least 2 of the following treatments, used for at least 3 months each: cyclophosphamide, mycophenolic ...

2. Relationship Between Data Obtained With The LuGENE® Multiparameter Transcriptomics Blood Test And Clinical And Standard Laboratory Features Of Patients With SLE (ReLATE) (ReLATE) - Mayo Clinic

   Have received intravenous glucocorticoids at a dosage of ≥ 500 mg daily within the past month; Have current drug or alcohol abuse or dependence, or a ...

3. Giant Cell Arteritis Vessel Wall Enhancement - Mayo Clinic

   Participant must be within 14 days of initiating or escalating systemic glucocorticoids (e.g., prednisone) OR have ongoing cranial symptoms concerning for ...

4. Trial of Anakinra (Plus Zinc), or Prednisone in Patients With Severe Alcoholic Hepatitis - Mayo Clinic

   Prior exposure to systemic corticosteroid (glucocorticoid) or immunosuppressive therapy for more than 4 days within previous 30 days 15. Need for inotropic ...

5. A Study to Assess Adrenal Aging in Menopausal Women - Mayo Clinic

   Ongoing exogenous glucocorticoid therapy. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to ...

6. Study of TERN-601 in Adults with Overweight or Obesity - Mayo Clinic

   ... glucocorticoids in the next 9 months. Have difficulty swallowing tablets ... glucocorticoid therapy (excluding topical, intraocular, intranasal, single ...

7. SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab - Mayo Clinic

   Subjects with interstitial lung disease or a history of pneumonitis that required oral or intravenous glucocorticoids to assist with management;; Subjects ...

8. Prevalence of Liver Disease in Patients Dependent on Parenteral Nutrition (THRIVE-1) - Mayo Clinic

   amiodarone, tamoxifen, methotrexate, tetracycline, glucocorticoids, anabolic steroids, over the usual dose of estrogen for hormone replacement therapy, and ...

9. Phase 2/3 Study Of KPL-387 In Recurrent Pericarditis - Mayo Clinic

   ... glucocorticoids (in any combination) Key Exclusion Criteria: * Phase 2 and 3: Has a diagnosis of pericarditis that is secondary to specific prohibited ...

10. SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing’s Syndrome - Mayo Clinic

    glucocorticoid replacement;; ACTH level > 20 pg/mL with positive ACTH or cortisol response to CRH or desmopressin (DDAVP) stimulation in the presence of ...